Why Colitis Research Draws Interest
Ulcerative colitis affects people across the world, and interest in regenerative research is growing. We look at the main reasons behind that interest and what the research still has to answer.
- Autoimmune
- 2 min
06/24/2026
A Common, Long-Term Condition
Inflammatory bowel disease, which includes ulcerative colitis, affects a large number of people worldwide. Because it is long-term and often unpredictable, it can shape work, diet, travel and relationships for years. That alone explains why patients follow new research so closely.
Symptoms such as abdominal pain, urgency and tiredness can return even after long quiet spells. Many people describe living with a constant awareness of the condition, which makes any news from research feel personal.
Why Interest Is Growing
Several factors have brought regenerative medicine into the conversation:
- Some patients continue to have symptoms despite standard treatment and want to understand other areas of study.
- In research settings, mesenchymal stem cells have shown an ability to influence immune activity and interact with tissue repair.
- More clinical studies are under way, so more information is reaching patients.
- Patients increasingly expect care that reflects their own history and goals.
What Research Still Has to Answer
Researchers and doctors are still working to define the role of stem cell treatment in ulcerative colitis. Important questions include which patients may benefit, how long any effect lasts and how cell therapy fits with existing medication. Until those answers are clearer, results will vary between patients, and nobody can predict how one person will respond. Larger and longer studies will be needed before firm conclusions can be drawn.
How Regeneration Clinic Fits In
We use mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords, produced in our in-house laboratory. Every patient has a medical evaluation, which decides whether treatment is appropriate.
Staying informed and talking openly with your own doctor remain the best foundation for any decision about your care.
06/24/2026
Related Articles
Frequently asked questions
Read Full FAQAnswers about safety, cost and what to expect.
Our proprietary stem cell standard, refined over 10 years of research and treatment. Sourced from Wharton’s Jelly and produced entirely in-house.
The most common side effect is temporary pain at the injection site. Headache, nausea or fatigue happen rarely and usually resolve within 24 hours. No long-term side effects have been documented to date.
In the US, FDA approval follows a long, costly path for each specific product and condition, and for most conditions mesenchymal stem cell therapy hasn’t completed that path yet. Research continues worldwide, with hundreds of clinical trials underway. Patients travel to Panama for access they can’t get at home, delivered with in-house production, image-guided precision and a team that tells them honestly what to expect.
We treat neurological, autoimmune, orthopedic and sports, cardiovascular and fertility conditions, autism, and support healthy aging. Our medical team reviews every case individually before recommending a protocol.
Yes. Treatment takes place at our clinic in Panama City. Your consultation and case review happen remotely before you book any travel.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance.

Still have a question?
Ask us directly. A patient advocate will reply personally.






